Log on / register
Feedback | Support | My details

Comments

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

Leah M Prentice email, Christian Klausen email, Steve Kalloger email, Martin Köbel email, Steven McKinney email, Jennifer L Santos email, Challayne Kenney email, Erika Mehl email, C Blake Gilks email, Peter Leung email, Ken Swenerton email, David G Huntsman email and Samuel AJ Aparicio email

BMC Medicine 2007, 5:33doi:10.1186/1741-7015-5-33

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.